Pellegrino Joseph P JR 4

What Happened
Joseph P. Pellegrino Jr., a director of LEMaitre Vascular, received a total of 19.144 dividend-equivalent rights (derivative awards) on June 4, 2026. These were reported as seven separate grant/acquisition entries (transaction code A) at $0.00 per share — these are dividend equivalents, not cash purchases or open‑market trades, and have no immediate cash value.

Key Details

• Transaction date: 2026-06-04; SEC filing date: 2026-06-05 (filed next day).
• Total granted/accrued: 19.144 dividend-equivalent rights (seven items: 1.824, 1.824, 3.117, 3.734, 3.384, 3.834, 1.427). Price reported $0.00.
• Type: Derivative awards (transaction code A — award/grant). Each dividend-equivalent right is the economic equivalent of one share and vests proportionately with the underlying award.
• Footnotes: Rights accrued on RSU and PSU awards granted on 12/12/2022 (F1,F2), 12/8/2023 (F3,F4), 12/6/2024 (F5,F6), and 12/10/2025 (F7).
• Shares owned after transaction: not specified in the provided filing.
• Timeliness: Filing appears timely (filed the day after the transaction).

Context
Dividend-equivalent rights are compensation-related crediting of dividends on outstanding RSUs/PSUs; they typically convert to shares (or cash) when the underlying awards vest. This is not a market purchase or sale and does not necessarily indicate an insider view on the company’s stock price—it's part of routine equity compensation.